Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Note 17 - Share-based Payments (Tables)

v3.19.2
Note 17 - Share-based Payments (Tables)
12 Months Ended
Mar. 31, 2019
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of share options [text block]
             
    March 31, 2019     March 31, 2018  
    Weighted average
exercise price
    Number of
options
    Weighted average
exercise price
    Number of
options
 
    $           $        
Outstanding at beginning of year    
1.81
     
2,284,388
     
2.58
     
1,424,788
 
Granted    
0.77
     
2,173,523
     
1.75
     
1,121,500
 
Exercised    
0.77
     
(4,167
)    
-
     
-
 
Forfeited    
1.84
     
(407,067
)    
1.89
     
(199,800
)
Expired    
-
     
-
     
18.06
     
(62,100
)
Outstanding at end of year    
1.25
     
4,046,677
     
1.81
     
2,284,388
 
                                 
Exercisable at end of year    
1.56
     
1,613,200
     
1.92
     
591,113
 
    Thirteen-month period
ended
March 31, 2017
    Month ended
March 31, 2017
    Twelve-month period
ended
February 28, 2017
 
    Weighted
average
exercise price
    Number
of options
    Weighted
average
exercise price
    Number
of options
    Weighted
average
exercise price
    Number
of options
 
    $           $           $        
Outstanding at beginning of period    
13.52
     
454,151
     
2.59
     
1,427,288
     
13.52
     
454,151
 
Granted    
1.69
     
1,300,400
     
-
     
-
     
1.69
     
1,300,400
 
Forfeited    
13.27
     
(190,138
)    
11.50
     
(2,500
)    
13.29
     
(187,638
)
Expired    
15.38
     
(139,625
)    
-
     
-
     
15.38
     
(139,625
)
Outstanding at end of period    
2.58
     
1,424,788
     
2.58
     
1,424,788
     
2.59
     
1,427,288
 
                                                 
Exercisable at end of period    
6.44
     
238,482
     
6.44
     
238,482
     
6.49
     
240,982
 
                Thirteen-month
period ended
    Twelve-month
Period ended
 
    March 31,
2019
    March 31,
2018
    March 31,
2017
    February 28, 2017
(Unaudited)
 
Weighted average fair value of the options granted to employees and directors of the Corporation   $
0.51
    $
1.22
    $
1.40
    $
1.40
 
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
                Thirteen-month
period ended
    Twelve-month
Period ended
 
    March 31, 2019     March 31, 2018     March 31, 2017     February 28, 2017
(Unaudited)
 
                         
Exercise price   $
0.77
    $
1.75
    $
1.69
    $
1.69
 
Share price   $
0.73
    $
1.75
    $
1.69
    $
1.69
 
Dividend    
-
     
-
     
-
     
-
 
Risk-free interest    
2.10
%    
1.21
%    
0.87
%    
0.87
%
Estimated life (in years)    
5.78
     
5.89
     
4.94
     
4.94
 
Expected volatility    
85.35
     
82.4
%    
123.5
%    
123.5
%
Disclosure of range of exercise prices of outstanding share options [text block]
        March 31, 2019  
        Options outstanding     Exercisable options  
Exercise price   Weighted remaining
contractual life
outstanding
    Number of options
outstanding
    Weighted average
exercise price
$
    Number of options
exercisable
 
                             
$0.77
-
$0.77
   
9.26
     
1,898,523
    $
0.77
     
348,197
 
$0.78
-
$1.58
   
5.86
     
775,000
    $
1.50
     
518,750
 
$1.59
-
$1.71
   
7.90
     
273,333
    $
1.65
     
233,333
 
$1.72
-
$1.88
   
8.21
     
790,833
    $
1.77
     
292,500
 
$1.89
-
$6.50
   
3.97
     
308,988
    $
2.57
     
220,420
 
 
 
 
   
7.91
     
4,046,677
    $
1.56
     
1,613,200